insights_auto
Why is OCEA down 60.00%?
Dive Deeperchevron_right
OCEA:OTCMKTS
Ocean Biomedical Inc
$0.00020
arrow_downward
-60.00%(-0.00030) 1D
Oct 15, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OCEA...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
32.07K
Avg. vol.
50.26K
Volume
57.56K
52-wk high
$0.01
52-wk low
$0.00
Beta
2.65
Shares outstanding
232.36M
No. of employees
7
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
32.07K
Avg. vol.
50.26K
Volume
57.56K
52-wk high
$0.01
52-wk low
$0.00
Beta
2.65
Shares outstanding
232.36M
No. of employees
7
News stories
From web sources and news partners
BigGo Finance
·
56 minutes ago
Dow Surges 556 Points as Philadelphia Semiconductor Index Extends Losing Streak to Seven Sessions; Capital Rotates into Defensive Stocks
marketscreener.com
·
1 hour ago
S&P 500 index rose slightly after Stockholm exchange close Thursday
Yahoo Finance
·
6 hours ago
Grayscale Says Bitcoin’s Volatility Falls to 43%, Now Within S&P 500 Range
The Motley Fool
·
3 hours ago
The S&P 500 Went More Than 50 Trading Days Without a 1% Drop. That Streak Just Ended. What's Next?
Profile
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
About Ocean Biomedical Inc